ACHILLES THERAPEUTICS PLC

CUSIP: 00449L102 Class: ADR

Redmile Group, LLC's Holding History (CIK: 0001425738)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 1,608,089 Value ($000) $1,833 Avg Close — Range —
Q3 2024
Shares 1,608,089 Value ($000) $1,640 Avg Close — Range —
Q2 2024
Shares 1,608,089 Value ($000) $1,311 Avg Close — Range —
Q1 2024
Shares 1,608,089 Value ($000) $2,010 Avg Close — Range —
Q4 2023
Shares 1,608,089 Value ($000) $1,430 Avg Close — Range —
Q3 2023
Shares 1,608,089 Value ($000) $1,463 Avg Close — Range —
Q2 2023
Shares 1,608,089 Value ($000) $1,520 Avg Close — Range —
Q1 2023
Shares 1,608,089 Value ($000) $1,540 Avg Close — Range —
Q4 2022
Shares 1,608,089 Value ($000) $1,447 Avg Close — Range —
Q3 2022
Shares 1,608,089 Value ($000) $3,634 Avg Close — Range —
Q2 2022
Shares 1,608,089 Value ($000) $4,052 Avg Close — Range —
Q1 2022
Shares 1,608,089 Value ($000) $4,728 Avg Close — Range —
Q4 2021
Shares 2,088,089 Value ($000) $10,461 Avg Close — Range —
Q3 2021
Shares 2,088,089 Value ($000) $16,266 Avg Close — Range —
Q2 2021
Shares 2,088,089 Value ($000) $20,442 Avg Close — Range —
Q1 2021
Shares 2,088,089 Value ($000) $34,558 Avg Close — Range —